Accuray (ARAY) – StreetInsider.com Reports
-
Accuray (ARAY) Opens New Facility in Genolier, Switzerland
-
Accuray (ARAY) Says New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife System
-
Accuray (ARAY) Announces Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System
-
Roth/MKM Starts Accuray (ARAY) at Buy
-
Accuray (ARAY) Misses Q2 EPS by 5c, Tops on Revenue; Offers FY24 Revenue Guidance
-
Accuray (ARAY) PT Lowered to $6.50 at B.Riley
-
Accuray (ARAY) Tops Q1 EPS by 2c
-
Accuray (ARAY) Announces Approval of the Tomo C Radiation Treatment Delivery System in China
-
Accuray (ARAY) Misses Q4 EPS by 4c ; Offers Guidance
-
Accuray (ARAY) Announces Its Addition to the Russell 2000 Index
-
Accuray (ARAY) Reports In-Line Q3 EPS; revenue, guidance beat
-
Accuray (ARAY) Tops Q2 EPS by 1c; Offers FY23 Guidance
-
Accuray (ARAY) Appoints Robert C. Kill to its Board
-
Accuray (ARAY) Announces Tomo C Registration Submission to China's National Medical Products Administration
-
Accuray (ARAY) Announces Accuray CyberKnife System Approved for Reimbursement in Japan
-
Accuray (ARAY) Reports Publication Showing Men With Prostate Cancer Treated With the Accuray CyberKnife Platform Experienced a Lower Incidence of Bladder Side Effects
-
Accuray (ARAY) Tops Q4 EPS by 2c
-
B.Riley Starts Accuray (ARAY) at Buy
-
Accuray (ARAY) Appoints Sandeep Chalke as Chief Commercial Officer
-
Accuray (ARAY) Tops Q3 EPS by 3c
-
Accuray (ARAY) Announces Suzanne Winter, President, Promoted to President and CEO; Joshua Levine Will Retire as CEO and Board Member
-
Accuray (ARAY) 10-Year Data Shows Accuray CyberKnife System Provides Long-Lasting Relief of the Excruciating Pain Caused by Trigeminal Neuralgia
-
Accuray's (ARAY) Accuray CyberKnife S7 Selected by CARTI to Increase Access to Advanced Cancer Care for Patients in Rural Communities Throughout Arkansas
-
Accuray (ARAY) Announces Largest Hospital in Queensland, Australia Acquires Multiple Radixact Systems
-
Accuray (ARAY) Reports In-Line Q2 EPS
-
UPDATE: Loop Capital Starts Accuray (ARAY) at Buy, 'Finally a Good Set Up'
-
Accuray (ARAY) CyberKnife Receives Shonin Approval to Treat Trigeminal Neuralgia
-
Accuray (ARAY) Tops Q1 EPS by 2c
-
Accuray (ARAY) Soars, Triggers Halt After Banyan Hill Tout - Bloomberg
-
Accuray (ARAY) halted on volatility after spike higher
-
Study Shows Accuray's (ARAY) CyberKnife Could Significantly Improve Survival in Early-Stage Breast Cancer Patients
-
Accuray (ARAY) Appoints Mika Nishimura to its Board
-
Accuray (ARAY) Misses Q4 EPS by 10c
-
Accuray (ARAY) Announces Promotion of Suzanne Winter to President
-
Accuray (ARAY) Reports In-Line Q3 EPS, Revenues Beat
-
Accuray (ARAY) Receives Shonin Approval for ClearRT Helical kVCT Imaging, CE Mark Expected by End of June; Expands Commercial Launch
-
Pre-Open Stock Movers 02/03: (TYME) (GWPH) (GOOGL) Higher; (VXRT) (VYGR) (TENB) Lower (more...)
-
After-Hours Stock Movers 02/02: (CLIR) (ARAY) (GOOGL) Higher; (VYGR) (PED) (MTCH) Lower (more...)
-
Accuray (ARAY) Director Whitters Buys 20K Shares
-
Accuray (ARAY) PT Raised to $9 at BTIG
-
Accuray (ARAY) Tops Q2 EPS by 7c
-
Accuray (ARAY) Announces Seven-year Data Shows System Provides Excellent Long-Term Control of Low-Risk Breast Cancer
-
UPDATE: Northland Capital Markets Starts Accuray (ARAY) at Outperform, $7 PT
-
Accuray (ARAY) Receives 510(k) FDA Clearance for ClearRT Helical kVCT Imaging for the Radixact Treatment Delivery System
-
Accuray (ARAY) Director Whitters Buys 50K Shares
-
Accuray (ARAY) Tops Q1 EPS by 7c
-
Accuray (ARAY) Spikes 3.8% as CMS Finalizes Radiation Payment Model - Bloomberg
-
Accuray (ARAY) Tops Q4 EPS by 1c
-
Accuray (ARAY) Names Anne B. Le Grand to Board
-
Pre-Open Stock Movers 04/29: (CMRX) (EAT) (GOOGL) Higher; (APRN) (TUP) (IRBT) Lower (more...)
Back to ARAY Stock Lookup